Music Broadcast Limited
₹5.38
+3.46%
Delayed · cached 15 min
Fair value analysis
RADIOCITY
Music Broadcast Limited
₹6.15
Close used for this calculation
₹33.24Fair value
The valuation models disagreed widely for this stock, so this figure is an unweighted average of the middle of their range. Treat it as indicative only.
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Quality radar
⚖️ Consensus Fair Value / Intrinsic Value (10 models)
₹33.24
▲ +440.5% vs the close used
Range: ₹29.48 – ₹45.38
● UNDERVALUED
₹33.24 fair value
The valuation models disagreed widely for this stock, so this figure is an unweighted average of the middle of their range. Treat it as indicative only.
🎯 Price Target Range & 52W Position
Bear₹29.48Fair Value₹33.24Bull₹45.38
FairNow
52W Low ₹4.6252W High ₹8.88
52W range measured from stored price history, not estimated.
📈 Valuation Summary
Trading Significantly Below Fair Value
Music Broadcast Limited closed at ₹6.15 — 81.5% below the consensus fair value of ₹33.24 drawn from 6 valuation models. P/E of 3.9x against the sector multiple the P/E model uses.
All 10 Valuation Models
DCF Valuation
₹33.24
+440.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
₹45.38
+637.8%
EPS × 25.35x (sector P/E)
EPS=1.79, Sector P/E=25.35x
Peter Lynch (PEG)
₹44.75
+627.6%
EPS × Growth% (PEG = 1 is fair)
EPS=1.79, g=25%
EV/EBITDA
₹32.08
+421.6%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=780M
Reverse DCF
₹6.15
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -10% | Historical: 25%
Margin of Safety
₹29.48
+379.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=39.31, MoS=25%
📊 Historical P/E Band
10-year P/E range — where does today's valuation sit historically?
Value zoneFair zonePremium zoneCurrent P/E
Sector 25.4xNow 3.9x
0x5x10x15x20x25x30x35x40x45x50x
Value ZoneFair ZonePremium
Value Zone — below sector rangeCurrent P/E: 3.9xSector P/E: 25.4x-84.5% vs sector avg
Key Metrics
ROE
139.00%
Benchmark: > 15%
✓ Good
ROCE
21.70%
Benchmark: > 15%
✓ Good
PAT Margin
23.38%
Benchmark: > 10%
✓ Good
D/E Ratio
5.14x
Benchmark: < 0.5x
✗ Below benchmark
EPS (TTM)
₹1.79
Benchmark: Higher is better
P/E Ratio
3.94x
Benchmark: < 25x
✓ Good
ICR
10.33x
Benchmark: > 3x
✓ Good
Cash PAT
63.00x
Benchmark: >= 0.9x
✓ Good
Computed on September 14, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Formula Guide
🪮 Financial DNA Score — How it's Calculated
Scored 0–100 across four equal pillars (0–25 each). Higher = stronger business quality.
Profitability (0–25)
PAT Margin + EPS Growth- PAT >20% → 15pts | >10% → 10pts | >5% → 5pts
- EPS growth >15% → 10pts | >8% → 7pts | >0% → 4pts
Returns (0–25)
ROE + ROCE + PE Sanity- ROE >20% → 10pts | >15% → 7pts | >10% → 4pts
- ROCE >20% → 8pts | >15% → 5pts
- PE <25x → 7pts | <35x → 5pts
Balance Sheet (0–25)
D/E + Current Ratio + Cash PAT- D/E=0 → 10pts | <0.5x → 7pts | <1x → 4pts
- CR >1.5x → 8pts | >1.2x → 5pts
- Cash PAT >1x → 7pts | >0.7x → 4pts
Efficiency (0–25)
Justified P/B + Dividend + Earnings Yield- P/B < justified P/B → 10pts
- Div Yield >2% → 8pts | >1% → 5pts
- Earnings Yield >5% → 7pts | >3% → 4pts
TCS example: ROE 51.8% (10) + ROCE 63% (8) + PE 15.6x (7) + PAT 18.5% (10) + D/E 0 (10) + CR 1.5x (8) + Div 1.8% (5) = 73/100 Strong
⚖️ Consensus Fair Value — How it's Calculated
Uses a sector-weighted composite — not a simple average — to prevent outlier models from distorting results.
Consensus = Σ(Model Value × Weight) ÷ Σ(Weights)
IT / Pharma / FMCG
- DCF — 50%
- P/E Fair Value — 30%
- Peter Lynch PEG — 20%
Banks / NBFCs
- Book Value (RIM) — 50%
- P/E Fair Value — 30%
- DDM — 20%
Cyclical / Metals / Auto
- EV/EBITDA — 50%
- DCF — 30%
- P/E Fair Value — 20%
Conglomerate / General
- DCF — 40%
- P/E Fair Value — 35%
- EV/EBITDA — 25%
⚠️ The Graham Number is shown for all stocks; for asset-light companies (ROE >40%, or ROE >20% with P/B >6) it reads low and is captioned as a rough floor. The Graham Formula is still excluded for those and for financial companies.
📐 10 Valuation Models — Formulas & Sector Guide
| Model | Formula | Best For | Avoid When |
|---|---|---|---|
| 1. DCF | Σ[FCF×(1+g)ⁿ/(1+r)ⁿ] + TV/(1+r)¹⁰ | IT, Pharma, FMCG | Banks, cyclicals, negative FCF |
| 2. Graham Number | √(22.5 × EPS × BVPS) | Asset-heavy value stocks | IT, FMCG (ROE>40%) |
| 3. Graham Formula | EPS × (8.5 + 2g) × 6.5 ÷ Bond Yield | INR stocks, moderate growth | Asset-light, US stocks |
| 4. P/E Fair Value | EPS × Sector PE Multiple | Universal | Loss-making companies |
| 5. Peter Lynch PEG | EPS × Growth% (PEG=1 is fair) | Growth companies | Low-growth, cyclicals |
| 6. EV/EBITDA | (EBITDA × Multiple − Net Debt) ÷ Shares | Metals, cement, auto | Banks, FMCG, asset-light |
| 7. DDM | D₁ ÷ (r − g), D₁ = D₀×(1+g) | Banks, utilities, mature payers | Non-dividend, growth stocks |
| 8. Justified P/B (RIM) | BVPS × (ROE−g) ÷ (r−g) | Banks, NBFCs, insurance | IT, FMCG asset-light |
| 9. Reverse DCF | Solve g: Price = Σ[EPS/(1+r)ⁿ] + TV | All stocks (diagnostic) | — |
| 10. Margin of Safety | Avg(DCF, Graham, P/E) × 75% | Conservative investors | High-growth stocks |
| Sector | Primary (50%) | Secondary (30%) | Third (20%) | Sector PE |
|---|---|---|---|---|
| IT / Software | DCF | P/E | Peter Lynch | 25x |
| Pharma | DCF | P/E | Peter Lynch | 28x |
| FMCG / Consumer | DCF | P/E | Graham Formula | 30x |
| Banks | Book Value RIM | P/E | DDM | 18x |
| NBFC | Book Value RIM | P/E | EV/EBITDA | 25x |
| Insurance / AMC | P/E | Book Value | DCF | 40x / 30x |
| Auto | EV/EBITDA | DCF | P/E | 22x |
| Metals / Steel | EV/EBITDA | Book Value | DCF | 8x |
| Utilities / Power | EV/EBITDA | DCF | P/E | 18x |
| Real Estate | Book Value (NAV) | DCF | P/E | 25x |
| Conglomerate | DCF | P/E | EV/EBITDA | 20x |
💧 Liquidity Stack — Formulas Explained
Three progressive ratios — each more conservative. Together they reveal the quality of short-term solvency.
Current Ratio
Current Assets ÷ Current Liabilities- Includes: Cash + Inventory + Receivables
- Benchmark: >1.2x ✓ <1.0x ✗
Quick Ratio
(Current Assets − Inventory) ÷ Current Liabilities- Excludes inventory (may not liquidate quickly)
- Benchmark: >1.0x ✓
Cash Ratio (Strictest)
Cash & Equivalents ÷ Current Liabilities- Only cash on hand — most conservative
- Benchmark: >0.2x ✓
Stack Gap Reading
Gap = Current − Quick- Gap <0.2 → Low inventory dependency ✓
- Gap >0.5 → Liquidity depends on selling stock
📏 Key Metrics — Benchmarks Explained
| Metric | Formula | Benchmark | What it Measures |
|---|---|---|---|
| ROE | Net Profit ÷ Shareholders' Equity | >15% | Efficiency of equity in generating profit |
| ROCE | EBIT ÷ Capital Employed | >15% | Returns on all capital (equity + debt) |
| PAT Margin | Net Profit ÷ Revenue | >10% | Profit per 100 of revenue |
| D/E Ratio | Total Debt ÷ Shareholders' Equity | <0.5x | Financial leverage — lower is safer |
| Current Ratio | Current Assets ÷ Current Liabilities | >1.2x | Short-term solvency |
| ICR | EBIT ÷ Interest Expense | >3x | Can earnings cover interest? |
| Cash PAT | Operating Cash Flow ÷ Net Profit | >0.9x | <0.9x suggests accounting inflation of profits |
| DSCR | (Net Income + D&A) ÷ Debt Service | >1.5x | Can the company service its debt? |
📊 Live Reference Output — RADIOCITY
This stock's full breakdown — DNA score, consensus fair value and every model — is in the Overview & summary and 10 valuation models tabs.
Educational data only. Not a recommendation to buy, sell or hold any security.